chartexchange

MRKR
Marker Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 2:55:12 PM EST
0.85USD+1.913%(+0.02)105,843
After-hoursNov 18, 2026 4:00:30 PM EST
0.8532USD+0.070%(+0.0006)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Houston, TX, USA
Previous Close
$0.84
Beta
1.27
52-Week High
$2.46 2026-01-08
52-Week Low
$0.81 2026-11-17
SMA 50
$1.04
SMA 200
$1.31
Avg. Vol 10D
120,316
Avg. Vol 30D
170,466
Avg. Vol 90D
100,898
Relative Vol
0.62
13.50M
0.8800%
Jan 27, 2023 · 1-for-10 (reverse)
MRKR Profile

tapimmune is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. the company's next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches and has the potential to be a powerful standalone therapy or part of a leading combination regimen by complementing other approved or development-stage immunotherapeutics (i.e. checkpoint inhibitors). the company's off-the-shelf vaccines boost patients' immune systems to comprehensively stimulate both killer t-cells and helper t-cells to destroy cancer cells, and they are designed to work with 80% of the population. tapimmune is advancing two clinical stage t-cell vaccine candidates in multiple phase ii and phase ib/iia clinical trials for treating ovarian and breast cancers, including programs in ovarian cancer that will benefit from fda fast track and orphan disease designation. the company is working in collaboration with industry and clini

MRKR Performance
PeriodPriceDateChangeBeta
1W0.952026-11-11-10.46%-0.062
1M1.202026-10-19-29.11%2.661
3M1.152026-08-18-26.03%2.260
6M1.392026-05-18-38.80%1.592
1Y1.012025-11-18-15.77%1.272
2Y2.932024-11-18-70.97%—
5Y12.602021-11-18-93.25%1.032
MRKR Stock Summary

Marker Therapeutics, Inc. Common Stock (NASDAQ:MRKR) stock price today is $0.85, and today's volume is 105,843. MRKR is up 1.685% today. The 30 day average volume is 170,466. MRKR market cap is $14.18M with 16.67M shares outstanding.